2024-11-26 09:41:51
Alterity Therapeutics Announces 1-for-10 Reverse ADS Split (consolidation)
Corporate/ 2023-07-24
Alterity Therapeutics Announces 1-for-10...

MELBOURNE,Australia and SAN FRANCISCO,Jan. 6,2023-- Alterity Therapeutics Limited ("Alterity" or the "Company") (ASX:ATH...

Ocedurenone (KBP-5074) Featured at ASN Kidney Week: Ocedurenone is a Potential New Treatment Option for Patients with Uncontrolled or Resistant Hypertension and Advanced CKD
Health/ 2023-07-22
Ocedurenone (KBP-5074) Featured at ASN K...

Hepatic Impairment and Drug-Drug Interaction Study Results Presented PRINCETON,N.J.,Jan. 6,2023--KBP Biosciences PTE. Ltd. ("KBP Biosci...

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release